Filing Details
- Accession Number:
- 0001209191-17-016507
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-02 16:04:07
- Reporting Period:
- 2017-03-01
- Filing Date:
- 2017-03-02
- Accepted Time:
- 2017-03-02 16:04:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1677618 | Rupert Vessey | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-01 | 4,000 | $124.42 | 778 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 135 | Indirect | 401(k) Plan |
Billionaire Hedge Funds
